You are viewing the site in preview mode

Skip to main content

Table 2 Number of acute medications by generic and drug class in the 183 days before and after index

From: Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study

Erenumab cohort Baseline Follow-up   
N = 3171 Number % Number % ORa (95% CI) P value
Number of generic drugs used
 0 872 27.5% 1170 36.9% 0.56 (0.51–0.63) < 0.0001
 1 1333 42.0% 1205 38.0%
 2 610 19.2% 514 16.2%
 3+ 356 11.2% 282 8.9%
Number of drug classes used
 0 872 27.5% 1170 36.9% 0.57 (0.51–0.64) < 0.0001
 1 1545 48.7% 1387 43.7%
 2 560 17.7% 453 14.3%
 3+ 194 6.1% 161 5.1%
  1. OR odds ratio, SD standard deviation
  2. aProportional odds model was used
Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us

\